Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-022732
Filing Date
2025-07-15
Accepted
2025-07-15 16:56:18
Documents
26
Period of Report
2025-08-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A urgn20250605_def14a.htm   iXBRL DEF 14A 1030382
6 ceocompensation.jpg GRAPHIC 42768
7 payvsperformancenetincomegra.jpg GRAPHIC 25645
8 payvsperformancetsrgraph.jpg GRAPHIC 25329
9 proxycard.jpg GRAPHIC 128208
10 proxycardpg2.jpg GRAPHIC 125526
11 urgn20240606_def14aimg001.jpg GRAPHIC 8504
12 urgn20240606_def14aimg002.jpg GRAPHIC 2387
13 urgn20240606_def14aimg004.jpg GRAPHIC 27235
14 urgn20240606_def14aimg005.jpg GRAPHIC 5474
15 urgn20240606_def14aimg006.jpg GRAPHIC 5258
16 urgn20240606_def14aimg007.jpg GRAPHIC 5044
  Complete submission text file 0001437749-25-022732.txt   2679196

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA urgn-20241231.xsd EX-101.SCH 5447
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20241231_def.xml EX-101.DEF 3208
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20241231_lab.xml EX-101.LAB 5112
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20241231_pre.xml EX-101.PRE 2516
28 EXTRACTED XBRL INSTANCE DOCUMENT urgn20250605_def14a_htm.xml XML 103150
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38079 | Film No.: 251125370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)